{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:56:01Z","timestamp":1790621761307,"version":"4.1.0"},"reference-count":48,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,5,1]]},"abstract":"<jats:sec>\n                  <jats:title>Learning Objectives<\/jats:title>\n                  <jats:p>After completing this course, the reader will be able to: Discuss the epidemiology of and the risk factors for anal cancer.Outline standard treatment for anal cancer and describe its complications.Understand the issues related to treating HIV-positive patients with anal cancer.<\/jats:p>\n                  <jats:p>CME Access and take the CME test online and receive 1 AMA PRA Category 1 Credit\u2122 at CME.TheOncologist.com<\/jats:p>\n               <\/jats:sec>","DOI":"10.1634\/theoncologist.12-5-524","type":"journal-article","created":{"date-parts":[[2007,5,23]],"date-time":"2007-05-23T23:01:52Z","timestamp":1179961312000},"page":"524-534","source":"Crossref","is-referenced-by-count":135,"title":["Anal Cancer: An Overview"],"prefix":"10.1093","volume":"12","author":[{"given":"Hope E.","family":"Uronis","sequence":"first","affiliation":[{"name":"a Department of Medicine, Divisions of Medical Oncology and Hematology, Duke University Medical Center, Durham, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna C.","family":"Bendell","sequence":"additional","affiliation":[{"name":"b Department of Medicine, Division of Medical Oncology, Duke University Medical Center, Durham, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2007,5,1]]},"reference":[{"key":"2021122208300560300_R1","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1056\/NEJM200003163421107","article-title":"Carcinoma of the anal canal","volume":"342","author":"Ryan","year":"2000","journal-title":"N Engl J Med"},{"key":"2021122208300560300_R2","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s11307-005-0003-6","article-title":"Positron emission tomography for pretreatment staging and posttreatment evaluation in cancer of the anal canal","volume":"7","author":"Trautmann","year":"2005","journal-title":"Mol Imaging Biol"},{"key":"2021122208300560300_R3","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.ijrobp.2006.01.009","article-title":"FDG-PET\/CT in the evaluation of anal carcinoma","volume":"65","author":"Cotter","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2021122208300560300_R4","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1159\/000226964","article-title":"Diagnosis of anal carcinoma\u2013doctor's finger still the best?","volume":"48","author":"Tanum","year":"1991","journal-title":"Oncology"},{"key":"2021122208300560300_R5","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1007\/BF02554126","article-title":"Prognosis of cloacogenic and squamous cancers of the anal canal","volume":"29","author":"Salmon","year":"1986","journal-title":"Dis Colon Rectum"},{"key":"2021122208300560300_R6","first-page":"1","volume-title":"SEER Cancer Statistics Review, 1975\u20132003","author":"Ries","year":"2005"},{"key":"2021122208300560300_R7","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.soc.2003.12.005","article-title":"The etiology and epidemiology of anal cancer","volume":"13","author":"Welton","year":"2004","journal-title":"Surg Oncol Clin N Am"},{"key":"2021122208300560300_R8","first-page":"753","article-title":"Variants of squamous cell carcinoma of the anal canal and perianal skin and their relation to human papillomaviruses","volume":"59","author":"Frisch","year":"1999","journal-title":"Cancer Res"},{"key":"2021122208300560300_R9","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/cncr.20365","article-title":"Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer","volume":"101","author":"Daling","year":"2004","journal-title":"Cancer"},{"key":"2021122208300560300_R10","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00384-001-0369-0","article-title":"The pathology and molecular biology of anal intraepithelial neoplasia: Comparisons with cervical and vulvar intraepithelial carcinoma","volume":"17","author":"Zbar","year":"2002","journal-title":"Int J Colorectal Dis"},{"key":"2021122208300560300_R11","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1056\/NEJM199711063371904","article-title":"Sexually transmitted infection as a cause of anal cancer","volume":"337","author":"Frisch","year":"1997","journal-title":"N Engl J Med"},{"key":"2021122208300560300_R12","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S1470-2045(04)01410-X","article-title":"Cancer of the anal canal","volume":"5","author":"Clark","year":"2004","journal-title":"Lancet Oncol"},{"key":"2021122208300560300_R13","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1056\/NEJM198710153171601","article-title":"Sexual practices, sexually transmitted diseases, and the incidence of anal cancer","volume":"317","author":"Daling","year":"1987","journal-title":"N Engl J Med"},{"key":"2021122208300560300_R14","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1093\/oxfordjournals.aje.a116270","article-title":"Cigarette smoking and the risk of anogenital cancer","volume":"135","author":"Daling","year":"1992","journal-title":"Am J Epidemiol"},{"issue":"23","key":"2021122208300560300_R15","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/oxfordjournals.jncimonographs.a024166","article-title":"Human papillomavirus infection and anogenital neoplasia in human immunodeficiency virus-positive men and women","author":"Palefsky","year":"1998","journal-title":"J Natl Cancer Inst Monogr"},{"key":"2021122208300560300_R16","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1097\/00002030-199511000-00007","article-title":"Prospective study of high grade anal squamous intraepithelial neoplasia in a cohort of homosexual men: Influence of HIV infection, immunosuppression and human papillomavirus infection","volume":"9","author":"Critchlow","year":"1995","journal-title":"AIDS"},{"key":"2021122208300560300_R17","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/00042560-199804010-00004","article-title":"Virologic, immunologic, and clinical parameters in the incidence and progression of anal squamous intraepithelial lesions in HIV-positive and HIV-negative homosexual men","volume":"17","author":"Palefsky","year":"1998","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"2021122208300560300_R18","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/00002030-199805000-00011","article-title":"High incidence of anal high-grade squamous intra-epithelial lesions among HIV-positive and HIV-negative homosexual and bisexual men","volume":"12","author":"Palefsky","year":"1998","journal-title":"AIDS"},{"key":"2021122208300560300_R19","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1002\/(SICI)1097-0142(20000315)88:6<1464::AID-CNCR26>3.0.CO;2-O","article-title":"Human papillomavirus-associated carcinomas in Hawaii and the mainland U.S","volume":"88","author":"Frisch","year":"2000","journal-title":"Cancer"},{"key":"2021122208300560300_R20","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/01.qai.0000159669.80207.12","article-title":"A population-based analysis of temporal trends in the incidence of squamous anal canal cancer in relation to the HIV epidemic","volume":"40","author":"Chiao","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2021122208300560300_R21","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1001\/jama.281.19.1822","article-title":"The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV-positive men","volume":"281","author":"Goldie","year":"1999","journal-title":"JAMA"},{"key":"2021122208300560300_R22","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/S0002-9343(00)00349-1","article-title":"Cost-effectiveness of screening for anal squamous intraepithelial lesions and anal cancer in human immunodeficiency virus-negative homosexual and bisexual men","volume":"108","author":"Goldie","year":"2000","journal-title":"Am J Med"},{"key":"2021122208300560300_R23","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/BF02586980","article-title":"Combined therapy for cancer of the anal canal: A preliminary report","volume":"17","author":"Nigro","year":"1974","journal-title":"Dis Colon Rectum"},{"key":"2021122208300560300_R24","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1200\/JCO.1996.14.9.2527","article-title":"Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: Results of a phase III randomized intergroup study","volume":"14","author":"Flam","year":"1996","journal-title":"J Clin Oncol"},{"key":"2021122208300560300_R25","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1200\/JCO.1997.15.5.2040","article-title":"Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: Results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups","volume":"15","author":"Bartelink","year":"1997","journal-title":"J Clin Oncol"},{"key":"2021122208300560300_R26","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0140-6736(96)03409-5","article-title":"Epidermoid anal cancer: Results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research","volume":"348","year":"1996","journal-title":"Lancet"},{"key":"2021122208300560300_R27","first-page":"238","article-title":"Combined-modality therapy of poor prognosis anal canal carcinomas: A phase II study of the Cancer and Leukemia Group B (CALGB)","volume-title":"ASCO Gastrointestinal Cancers Symposium","author":"Meropol","year":"2005"},{"key":"2021122208300560300_R28","doi-asserted-by":"crossref","first-page":"4009","DOI":"10.1200\/jco.2006.24.18_suppl.4009","article-title":"Intergroup RTOG 98\u201311: A phase III randomized study of 5-fluorouracil (5-FU), mitomycin, and radiotherapy versus 5-FU, cisplatin and radiotherapy in carcinoma of the anal canal","volume":"24","author":"Ajani","year":"2006","journal-title":"Proc Am Soc Clin Oncol"},{"key":"2021122208300560300_R29","first-page":"1151","article-title":"The second UK phase III anal cancer trial of chemoradiation and maintenance therapy (ACT II): Preliminary results on toxicity and outcome","volume":"22","author":"James","year":"2003","journal-title":"Proc Am Soc Clin Oncol"},{"key":"2021122208300560300_R30","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1002\/1097-0142(19830515)51:10<1826::AID-CNCR2820511012>3.0.CO;2-L","article-title":"Combined preoperative radiation and chemotherapy for squamous cell carcinoma of the anal canal","volume":"51","author":"Nigro","year":"1983","journal-title":"Cancer"},{"key":"2021122208300560300_R31","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1038\/sj.bjc.6690567","article-title":"Assessment of long-term quality of life in patients with anal carcinomas treated by radiotherapy with or without chemotherapy","volume":"80","author":"Allal","year":"1999","journal-title":"Br J Cancer"},{"key":"2021122208300560300_R32","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0360-3016(98)00528-8","article-title":"The significance of pretreatment CD4 count on the outcome and treatment tolerance of HIV-positive patients with anal cancer","volume":"44","author":"Hoffman","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2021122208300560300_R33","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1007\/BF02050594","article-title":"Squamous cell carcinoma of the anus and HIV infection","volume":"34","author":"Lorenz","year":"1991","journal-title":"Dis Colon Rectum"},{"key":"2021122208300560300_R34","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/S0360-3016(96)00596-2","article-title":"Chemotherapy and low-dose radiotherapy in the treatment of HIV-infected patients with carcinoma of the anal canal","volume":"37","author":"Peddada","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2021122208300560300_R35","doi-asserted-by":"crossref","first-page":"986","DOI":"10.3109\/02841869109088255","article-title":"Carcinoma of the anal canal in a patient with AIDS","volume":"30","author":"Svensson","year":"1991","journal-title":"Acta Oncol"},{"key":"2021122208300560300_R36","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1007\/BF02234605","article-title":"HIV-positive patients with anal carcinoma have poorer treatment tolerance and outcome than HIV-negative patients","volume":"44","author":"Kim","year":"2001","journal-title":"Dis Colon Rectum"},{"key":"2021122208300560300_R37","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0936-6555(05)80720-4","article-title":"Epidermoid anal cancer in HIV infected patients","volume":"8","author":"Bottomley","year":"1996","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"2021122208300560300_R38","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/S0959-8049(00)00009-5","article-title":"Treatment of HIV-associated invasive anal cancer with combined chemoradiation","volume":"36","author":"Cleator","year":"2000","journal-title":"Eur J Cancer"},{"key":"2021122208300560300_R39","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1148\/radiology.193.1.8090901","article-title":"Tolerance of patients with human immunodeficiency virus and anal carcinoma to treatment with combined chemotherapy and radiation therapy","volume":"193","author":"Holland","year":"1994","journal-title":"Radiology"},{"key":"2021122208300560300_R40","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/BF02052589","article-title":"Squamous-cell carcinoma of the anus in HIV-positive patients","volume":"37","author":"Chadha","year":"1994","journal-title":"Dis Colon Rectum"},{"key":"2021122208300560300_R41","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1007\/BF02234322","article-title":"Outcome analysis of HIV-positive patients with anal squamous cell carcinoma","volume":"44","author":"Place","year":"2001","journal-title":"Dis Colon Rectum"},{"key":"2021122208300560300_R42","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/bjs.4908","article-title":"Patterns of local disease failure and outcome after salvage surgery in patients with anal cancer","volume":"92","author":"Renehan","year":"2005","journal-title":"Br J Surg"},{"key":"2021122208300560300_R43","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1046\/j.1365-2168.2002.02231.x","article-title":"Salvage abdominoperineal resection in anal epidermoid cancer","volume":"89","author":"Nilsson","year":"2002","journal-title":"Br J Surg"},{"key":"2021122208300560300_R44","first-page":"1345","article-title":"Cisplatin plus 5-fluorouracil in the treatment of metastatic anal squamous cell carcinoma: A report of two cases","volume":"70","author":"Khater","year":"1986","journal-title":"Cancer Treat Rep"},{"key":"2021122208300560300_R45","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/00000421-199312000-00017","article-title":"Cisplatin and 5-fluorouracil as salvage therapy for recurrent metastatic squamous cell carcinoma of the anal canal","volume":"16","author":"Jaiyesimi","year":"1993","journal-title":"Am J Clin Oncol"},{"key":"2021122208300560300_R46","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0936-6555(05)80699-5","article-title":"Response of metastatic anal carcinoma to single agent carboplatin","volume":"5","author":"Evans","year":"1993","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"2021122208300560300_R47","first-page":"91","article-title":"Metastatic cloacogenic carcinoma of the anus: Sequential responses to adriamycin and cis-dichlorodiammineplatinum(II)","volume":"62","author":"Fisher","year":"1978","journal-title":"Cancer Treat Rep"},{"key":"2021122208300560300_R48","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1002\/1097-0142(19811215)48:12<2569::AID-CNCR2820481206>3.0.CO;2-X","article-title":"Response of metastatic cloacogenic carcinoma to treatment with semustine","volume":"48","author":"Zimm","year":"1981","journal-title":"Cancer"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1634\/theoncologist.12-5-524","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1634\/theoncologist.12-5-524","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/12\/5\/524\/41834961\/oncolo_12_5_524.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/12\/5\/524\/41834961\/oncolo_12_5_524.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,22]],"date-time":"2021-12-22T14:24:00Z","timestamp":1640183040000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/12\/5\/524\/6410496"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5,1]]},"references-count":48,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2007,5,1]]},"published-print":{"date-parts":[[2007,5,1]]}},"URL":"https:\/\/doi.org\/10.1634\/theoncologist.12-5-524","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2007,5,1]]},"published":{"date-parts":[[2007,5,1]]}}}